Retrospective review of cerebral mycotic aneurysms in 26 patients: Focus on treatment in strongly immunocompromised patients with a brief literature review

Keyphrases

• Retrospective Review 100%
• Aneurysm 100%
• Antibiotics 100%
• Patient-centered 100%
• Immunocompromised Patients 100%
• Endovascular 100%
• Invasive Treatment 100%
• Immunocompromised State 100%
• Cerebral Mycotic Aneurysm 100%
• Risk Factors 50%
• Electronic Medical Records 50%
• Immunosuppression 50%
• High Morbidity 50%
• High Mortality 50%
• Clinical Efficacy 50%
• Chemotherapy 50%
• Clinical Practice Guidelines 50%
• Rapid Growth 50%
• Patient Demographics 50%
• Anticoagulation 50%
• Definitive Treatment 50%
• Patient Identification 50%
• Technical Success 50%
• Multi-institutional Study 50%
• Craniotomy 50%
• Alternative Diagnosis 50%
• Angiographic Findings 50%
• Neurologic Complications 50%
• Valve Replacement 50%
• Medical Imaging 50%
• Aneurysm Size 50%
• Endovascular Treatment 50%
• Imaging Report 50%
• Emergent Treatment 50%
• Causing Death 50%
• Acute Period 50%
• Aneurysm Occlusion 50%
• Non-invasive Treatment 50%
• Infectious Etiology 50%
• Anticoagulation Reversal 50%
• Cardiac Valves 50%
• Angiographic Follow-up 50%
• Valve Repair 50%
• Recanalization Rate 50%

Medicine and Dentistry

• Immunocompromised Patient 100%
• Array Comparative Genomic Hybridization 100%
• Mycotic Aneurysm 100%
• Aneurysm 44%
• Anticoagulation 22%
• Invasive Procedure 22%
• Antibiotics 22%
• Electronic Patient Record 11%
• Immunosuppressive Treatment 11%
• Patient Population 11%
• Non Invasive Procedure 11%
• Craniotomy 11%
• Recanalization 11%
• Neurological Complication 11%
• Valve Replacement 11%
• Medical Imaging 11%
• Valvuloplasty 11%
• Heart Valve 11%